Boothbay Fund Management, LLC Intercept Pharmaceuticals, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $5.4 Million - $8.71 Million	442,300 Added 989.49%	487,000 $6.79 Million
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $501,981 - $875,673	44,700 New	44,700 $617,000
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $2.7 Million - $3.59 Million	-201,600 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $2.31 Million - $3.16 Million	161,600 Added 404.0%	201,600 $3.28 Million
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $519,600 - $818,800	40,000 New	40,000 $594,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.